Sep 28

Clinical Trials

CT 01 - Clinical Trials

San Francisco Ballroom

01:00pm - 02:30pm PT

Special Session

MODERATOR(S)

Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai

Farzan Siddiqui, MD, PhD - Henry Ford Hospital/Wayne State University

Credits

AMA PRA Category 1 Credits:

1.50

Presentations

01:00pm - 02:30pm PT

Clinical Trials

Speaker: Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai, New York
01:00pm - 02:30pm PT

Clinical Trials

Speaker: Farzan Siddiqui, MD, PhD - Henry Ford Hospital/Wayne State University, Detroit
01:00pm - 01:10pm PT

177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer; Primary Endpoint Analysis of the Phase II LUNAR Randomized Trial

Speaker: Amar Kishan, MD, PhD - UCLA, Culver City
01:10pm - 01:20pm PT

Decreasing the Dose of Consolidation Radiation Therapy in DLBCL/HGBL: A Phase II Trial by the International Lymphoma Radiation Oncology Group

Speaker: Christopher Kelsey, MD, FASTRO - Duke University Medical Center, Durham